Of these phytochemicals, sulforaphane has also been tested in clinical trials that examined its efficacy in autistic-type behaviors (158, 159) and showed very good results in reducing and improving symptoms, through activation of the NRF2 pathway, combined with a favorable safety profile in children with autism. The gene discussed is NFE2L2; the disease is autism.